ALOPECIA AREATA
Clinical trials for ALOPECIA AREATA explained in plain language.
Never miss a new study
Get alerted when new ALOPECIA AREATA trials appear
Sign up with your email to follow new studies for ALOPECIA AREATA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection tested to regrow hair in severe alopecia
Disease control OngoingThis study is testing whether an investigational drug called rezpegaldesleukin, given as an injection, can help regrow hair in adults with severe to very severe alopecia areata. About 94 participants will be randomly assigned to receive either the drug or a placebo (an inactive s…
Matched conditions: ALOPECIA AREATA
Phase: PHASE2 • Sponsor: Nektar Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New injection shows promise for reversing severe hair loss
Disease control OngoingThis study is testing whether an injectable medication called bempikibart can help regrow hair in adults with severe alopecia areata, a condition causing significant hair loss. Participants receive injections every two weeks, and researchers measure changes in scalp hair coverage…
Matched conditions: ALOPECIA AREATA
Phase: PHASE2 • Sponsor: Q32 Bio Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Hair loss pill gets Long-Term safety check in major trial
Disease control OngoingThis study is following up with 1,000 adults who have moderate to severe alopecia areata, a condition causing patchy hair loss. The goal is to see if an oral medication called CTP-543 is safe and continues to help regrow hair when taken for a longer period. Participants had alrea…
Matched conditions: ALOPECIA AREATA
Phase: PHASE2, PHASE3 • Sponsor: Sun Pharmaceutical Industries, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New injection shows promise for reversing severe hair loss
Disease control OngoingThis study is testing whether a new injectable drug called amlitelimab can help regrow hair in adults with severe alopecia areata, an autoimmune condition causing significant hair loss. 166 participants will receive either the drug or a placebo via injection for 36 weeks, followe…
Matched conditions: ALOPECIA AREATA
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Could vitamin d boost hair regrowth after microneedling?
Disease control OngoingThis study compares two treatments for patchy hair loss (alopecia areata). One group gets microneedling alone, where tiny needles create micro-injuries to stimulate the scalp. The other gets microneedling plus topical vitamin D3, which may help calm the immune attack on hair foll…
Matched conditions: ALOPECIA AREATA
Phase: NA • Sponsor: Services Institute of Medical Sciences, Pakistan • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Pfizer tracks Real-World results of hair loss drug
Disease control OngoingThis study is monitoring the long-term safety and effectiveness of Litfulo capsules in people with alopecia areata (an autoimmune hair loss condition) during real-world use. It will follow about 500 patients who are starting the medication for the first time. The main goals are t…
Matched conditions: ALOPECIA AREATA
Sponsor: Pfizer • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Hair regrowth hope: major trial tests Long-Term alopecia pill
Disease control OngoingThis large, long-term study is testing the safety and effectiveness of an oral medication called PF-06651600 for people with alopecia areata, an autoimmune condition that causes hair loss. Over 1,000 adults and adolescents (age 12+) will receive the active drug to see if it helps…
Matched conditions: ALOPECIA AREATA
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC